Abstract
Muscle injury and degenerative muscle disease is a disabling condition in sport medicine and a challenging problem in orthopedic surgery. Upon traumatic or degenerative changes in the structure of the muscle, regeneration befalls mainly by increased proliferation of satellite cells. If the injury is extensive fibrosis and scar tissue formation occurs. Till now various alternative therapeutic ways have been proposed to boost muscle regeneration. These methods include the use of growth factors, antioxidative therapy, cell based therapy and cell transplantation as well as the use of scaffolds. Growth factors, antioxidative substances and endogenous polypeptides can not only influence but also control the natural repair processes by acting on different intracellular pathways. Cell orientated therapies have been popular in muscle regeneration mainly because small quantities of cells are needed to achieve therapeutic effects. Transplantation of stem cells, myoblasts and genetically modified cells has been used after injury to restore muscle structure and function. Furthermore scaffolds have been used to repair muscle defects and to generate new muscle fibers. Similar approaches have been made for regeneration of ligaments. There are a number of cell sources that are potentially helpful for cell mediated tissue regeneration. Scaffolds provide temporary mechanical support and can carry cells which promote the ligament regeneration. Furthermore growth factors can be used to stimulate ligament healing and accelerate regeneration mainly by modulating the proliferation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amiel D, Kleiner J B, Roux R D, et al. (1986) The phenomenon of “ligamentization”: anterior cruciate ligament reconstruction with autogenous patellar tendon. J Orthop Res 4: 162–172.
Arai C, Ohnuki Y, Umeki D, et al. (2006) Effects of clenbuterol and cyclosporin A on the myosin heavy chain mRNA level and the muscle mass in rat masseter. J Physiol Sci 56: 205–209.
Armour J, Tyml K, Lidington D, et al. (2001) Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol 90: 795–803.
Arthur A, Zannettino A, Gronthos S (2009) The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 218: 237–245.
Barton E R, Morris L, Musaro A, et al. (2002) Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157: 137–148.
Baskin C R, Hinchcliff K W, DiSilvestro R A, et al. (2000) Effects of dietary antioxidant supplementation on oxidative damage and resistance to oxidative damage during prolonged exercise in sled dogs. Am J Vet Res 61: 886–891.
Bolcal C, Yildirim V, Doganci S, et al. (2007) Protective effects of antioxidant medications on limb ischemia reperfusion injury. J Surg Res 139: 274–279.
Caplan A I (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341–347.
Charge S B and Rudnicki M A (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209–238.
Ciciliot S and Schiaffino S (2009) Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications. Curr Pharm Des [Epub ahead of print].
Cooper J A, Lu H H, Ko F K, et al. (2005) Fiber-based tissue-engineered scaffold for ligament replacement: design considerations and in vitro evaluation. Biomaterials 26: 1523–1532.
Corbel S Y, Lee A, Yi L, et al. (2003) Contribution of hematopoietic stem cells to skeletal muscle. Nat Med 9: 1528–1532.
De Bari C, Dell’Accio F, Vandenabeele F, et al. (2003) Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 160: 909–918.
Deehan D J and Cawston T E (2005) The biology of integration of the anterior cruciate ligament. J Bone Joint Surg Br 87: 889–895.
DesRosiers E A, Yahia L and Rivard C H (1996) Proliferative and matrix synthesis response of canine anterior cruciate ligament fibroblasts submitted to combined growth factors. J Orthop Res 14: 200–208.
Dezawa M, Ishikawa H, Itokazu Y, et al. (2005) Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309: 314–317.
Evans W J (2000) Vitamin E, vitamin C, and exercise. Am J Clin Nutr 72: 647 S–652 S.
Fan H, Liu H, Toh S L, et al. (2009) Anterior cruciate ligament regeneration using mesenchymal stem cells and silk scaffold in large animal model. Biomaterials 30: 4967–4977.
Fan H, Liu H, Wong E J, et al. (2008) In vivo study of anterior cruciate ligament regeneration using mesenchymal stem cells and silk scaffold. Biomaterials 29: 3324–3337.
Farini A, Razini P, Erratico S, et al. (2009) Cell based therapy for Duchenne muscular dystrophy. J Cell Physiol 221: 526–534.
Ferrari G, Cusella-De Angelis G, Coletta M, et al. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 1528–1530.
Galli R, Pagano S F, Gritti A, et al. (2000) Regulation of neuronal differentiation in human CNS stem cell progeny by leukemia inhibitory factor. Dev Neurosci 22: 86–95.
Grefte S, Kuijpers-Jagtman A M, Torensma R, et al. (2007) Skeletal muscle development and regeneration. Stem Cells Dev 16: 857–868.
Gussoni E, Blau H M and Kunkel L M (1997) The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3: 970–977.
Gussoni E, Pavlath G K, Lanctot A M, et al. (1992) Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356: 435–438.
Hildebrand K A, Woo S L, Smith D W, et al. (1998) The effects of platelet-derived growth factor-BB on healing of the rabbit medial collateral ligament. An in vivo study. Am J Sports Med 26: 549–554.
Hill E, Boontheekul T and Mooney D J (2006) Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng 12: 1295–1304.
Hill E, Boontheekul T and Mooney D J (2006) Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci U S A 103: 2494–2499.
Huang Y C, Dennis R G, Larkin L, et al. (2005) Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol 98: 706–713.
Husmann I, Soulet L, Gautron J, et al. (1996) Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev 7: 249–258.
Ignatius A and Durselen L (2009) [Possibilities and limits in tissue engineering of the anterior cruciate ligament.]. Orthopade 38: 1080–1086.
Irintchev A, Langer M, Zweyer M, et al. (1997) Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts. J Physiol 500 (Pt 3): 775–785.
Israeli D, Benchaouir R, Ziaei S, et al. (2004) FGF6 mediated expansion of a resident subset of cells with SP phenotype in the C2C12 myogenic line. J Cell Physiol 201: 409–419.
Järvinen T A, Järvinen T L, Kääriäinen M, et al. (2005) Muscle injuries: biology and treatment. Am J Sports Med 33: 745–764.
Jiang Y, Vaessen B, Lenvik T, et al. (2002) Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30: 896–904.
Kamelger F S, Marksteiner R, Margreiter E, et al. (2004) A comparative study of three different biomaterials in the engineering of skeletal muscle using a rat animal model. Biomaterials 25: 1649–1655.
Karalaki M, Fili S, Philippou A, et al. (2009) Muscle regeneration: cellular and molecular events. In Vivo 23: 779–796.
Kearns S R, Daly A F, Sheehan K, et al. (2004) Oral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome. J Bone Joint Surg Br 86: 906–911.
Kim E K and Hong J P (2007) The effect of recombinant human erythropoietin on ischemia-reperfusion injury: an experimental study in a rat TRAM flap model. Plast Reconstr Surg 120: 1774–1781.
Kon M, Kimura F, Akimoto T, et al. (2007) Effect of Coenzyme Q10 supplementation on exercise-induced muscular injury of rats. Exerc Immunol Rev 13: 76–88.
Krampera M, Franchini M, Pizzolo G, et al. (2007) Mesenchymal stem cells: from biology to clinical use. Blood Transfus 5: 120–129.
LaBarge M A and Blau H M (2002) Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111: 589–601.
Li J, Yang L, Liu K, et al. (2009) Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model. Microvasc Res.
Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9: 493–495.
McKay B R, O’Reilly C E, Phillips S M, et al. (2008) Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans. J Physiol 586: 5549–5560.
Mendell J R, Kissel J T, Amato A A, et al. (1995) Myoblast transfer in the treatment of Duchenne’s muscular dystrophy. N Engl J Med 333: 832–838.
Menetrey J, Kasemkijwattana C, Day C S, et al. (1999) Direct-, fibroblast- and myoblast-mediated gene transfer to the anterior cruciate ligament. Tissue Eng 5: 435–442.
Mitchell P O and Pavlath G K (2002) Multiple roles of calcineurin in skeletal muscle growth. Clin Orthop Relat Res S197–202.
Motohashi N, Uezumi A, Yada E, et al. (2008) Muscle CD31(-) CD45(-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts. Am J Pathol 173: 781–791.
Mourkioti F and Rosenthal N (2008) NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases. J Mol Med 86: 747–759.
Muguruma Y, Reyes M, Nakamura Y, et al. (2003) In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells. Exp Hematol 31: 1323–1330.
Naito T, Goto K, Morioka S, et al. (2009) Administration of granulocyte colony-stimulating factor facilitates the regenerative process of injured mice skeletal muscle via the activation of Akt/GSK3alphabeta signals. Eur J Appl Physiol 105: 643–651.
Oestern H J and Tscherne H (1983) [Physiopathology and classification of soft tissue lesion]. Hefte Unfallheilkd 162: 1–10.
Otto A, Collins-Hooper H and Patel K (2009) The origin, molecular regulation and therapeutic potential of myogenic stem cell populations. J Anat 215: 477–497.
Peterson J M and Guttridge D C (2008) Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention. Int Rev Immunol 27: 375–387.
Price F D, Kuroda K and Rudnicki M A (2007) Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta 1772: 272–283.
Qu Z, Balkir L, van Deutekom J C, et al. (1998) Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142: 1257–1267.
Reznick A Z, Witt E, Matsumoto M, et al. (1992) Vitamin E inhibits protein oxidation in skeletal muscle of resting and exercised rats. Biochem Biophys Res Commun 189: 801–806.
Rodriguez A M, Pisani D, Dechesne C A, et al. (2005) Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 201: 1397–1405.
Rotter R, Menshykova M, Winkler T, et al. (2008) Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue. J Orthop Res 26: 1618–1626.
Saxena A K, Marler J, Benvenuto M, et al. (1999) Skeletal muscle tissue engineering using isolated myoblasts on synthetic biodegradable polymers: preliminary studies. Tissue Eng 5: 525–532.
Saxena A K, Willital G H and Vacanti J P (2001) Vascularized three-dimensional skeletal muscle tissue-engineering. Biomed Mater Eng 11: 275–281.
Sherwood R I, Christensen J L, Weissman I L, et al. (2004) Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. Stem Cells 22: 1292–1304.
Singleton J R and Feldman E L (2001) Insulin-like growth factor-I in muscle metabolism and myotherapies. Neurobiol Dis 8: 541–554.
Stratos I, Rotter R, Eipel C, et al. (2007) Granulocyte-colony stimulating factor enhances muscle proliferation and strength following skeletal muscle injury in rats. Journal of applied physiology (Bethesda, Md : 1985) 103: 1857–1863.
Takahashi T, Kalka C, Masuda H, et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434–438.
Torrente Y, Belicchi M, Sampaolesi M, et al. (2004) Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 114: 182–195.
Wagner K R (2005) Muscle regeneration through myostatin inhibition. Curr Opin Rheumatol 17: 720–724.
Warren J A, Jenkins R R, Packer L, et al. (1992) Elevated muscle vitamin E does not attenuate eccentric exercise-induced muscle injury. J Appl Physiol 72: 2168–2175.
Wernig A, Zweyer M and Irintchev A (2000) Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles. J Physiol 522 Pt 2: 333–345.
Woo S L, Jia F, Zou L, et al. (2004) Functional tissue engineering for ligament healing: potential of antisense gene therapy. Ann Biomed Eng 32: 342–351.
Yimlamai T, Dodd S L, Borst S E, et al. (2005) Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. J Appl Physiol 99: 71–80.
You T, Goldfarb A H, Bloomer R J, et al. (2005) Oxidative stress response in normal and antioxidant supplemented rats to a downhill run: changes in blood and skeletal muscles. Can J Appl Physiol 30: 677–689.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Netherlands
About this chapter
Cite this chapter
Mittlmeier, T., Stratos, I. (2011). Muscle and Ligament Regeneration. In: Steinhoff, G. (eds) Regenerative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9075-1_38
Download citation
DOI: https://doi.org/10.1007/978-90-481-9075-1_38
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9074-4
Online ISBN: 978-90-481-9075-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)